Inhibrx Biosciences, Inc. (INBX)
NASDAQ: INBX · Real-Time Price · USD
23.50
-0.07 (-0.30%)
Aug 14, 2025, 2:21 PM - Market open

Inhibrx Biosciences Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22
Cash & Equivalents
186.57152.6277.92-
Cash & Short-Term Investments
186.57152.6277.92-
Cash Growth
-17.76%-45.09%--
Accounts Receivable
0.240.40.780.24
Other Receivables
0.730.02-0.01
Receivables
0.970.420.780.26
Inventory
-29.890.81
Prepaid Expenses
6.434.195.674.53
Other Current Assets
-1.21.090.67
Total Current Assets
193.96160.4295.366.26
Property, Plant & Equipment
11.3513.549.377.22
Other Long-Term Assets
6.816.833.163.16
Total Assets
212.12180.77307.8916.65
Accounts Payable
8.2914.8933.769.45
Accrued Expenses
28.4824.2520.499.46
Current Portion of Leases
2.171.62.061.86
Total Current Liabilities
38.9440.7356.3120.77
Long-Term Debt
99.28-206.97-
Long-Term Leases
5.346.451.113.17
Total Liabilities
143.5647.18264.3923.95
Common Stock
000.01-7.3
Additional Paid-In Capital
246.66239.72657.23-
Retained Earnings
-178.1-106.13-613.73-
Shareholders' Equity
68.56133.5843.5-7.3
Total Liabilities & Equity
212.12180.77307.8916.65
Total Debt
106.798.05210.145.03
Net Cash (Debt)
79.78144.5567.78-5.03
Net Cash Growth
-64.49%113.25%--
Net Cash Per Share
5.169.655.75-
Filing Date Shares Outstanding
14.4914.4811.78-
Total Common Shares Outstanding
14.4814.4811.78-
Working Capital
155.03119.67239.05-14.51
Book Value Per Share
4.749.233.69-
Tangible Book Value
68.56133.5843.5-7.3
Tangible Book Value Per Share
4.749.233.69-
Machinery
-10.319.027.55
Construction In Progress
--3.59-
Leasehold Improvements
-0.80.440.44
Updated Aug 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q